More on CMPX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.4 Score)

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Compass Therapeutics, Inc (NQ:CMPX)
Delayed: 2.05 -0.05 (2.38%)
Prev. Close $2.10  
Open$2.06 
52 Wk High$ 
52 Wk Low$ 
Day High$2.12 
Day Low$2.01 
P/E N/A  
EPS$ 
Volume2,143,118 

Friends, Peers and Foes (?): ABBV, AMGN, ARGX, ARWR, AVTX (more...)

Jul 17, 2026 10:42 AM Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026
Jul 1, 2026 05:01 PM Form 8-K Compass Therapeutics, For: Jul 01
Jul 1, 2026 06:35 AM Ladenburg Thalmann Assumes Compass Therapeutics (CMPX) at Buy
Jun 23, 2026 06:02 AM Form 8-K Compass Therapeutics, For: Jun 22
Jun 12, 2026 08:10 AM After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
Jun 11, 2026 04:01 PM Form 8-K Compass Therapeutics, For: Jun 10
Jun 4, 2026 05:22 AM Compass Therapeutics (CMPX) Reiterated at Market Outperform by Citizens
Jun 1, 2026 07:32 AM Compass Therapeutics (CMPX) Reiterated at Buy by Stifel After ASCO Presentation
May 28, 2026 07:30 AM Compass Therapeutics to Participate in Upcoming June Investor Events
May 21, 2026 05:00 PM Compass Therapeutics reports phase 1 data for CTX-8371 at ASCO meeting
View All Articles

Entities mentioned with CMPX

View All Entities